Skip to main content
Clinical Trials/NCT02178293
NCT02178293CompletedPhase 4

MISTRAL (Mouthwash In Sore Throat Relief: Antiinflammatory vs. Local Anesthetic Therapy) "Efficacy and Tolerability of Ketoprofen Lysine Salt as a Mouthwash in Acute Phlogosis of the Pharyngeal Cavity; Multicentre, Randomized, Single-blind, Parallel-group Comparison Versus Benzidamine Hydrochloride"

Boehringer Ingelheim0 sites214 target enrollmentStarted: September 1998Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
214
Primary Endpoint
Duration of analgesic effects in hours

Study Overview

Brief Summary

A study to in order to verify any differences between the 2 treatment groups in terms of duration of analgesic effects after the first drug intake and time to remission of symptoms and signs of pharyngitis

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male and female outpatients, aged 18 to 70 years, suffering from acute pharyngitis, pharyngolaryngitis
  • Moderately or severely intense pain in the pharyngeal region (score ≥ 70 mm) from the "visual analogue scale" (VAS)
  • At least 1 of the 2 inflammation signs (edema and hyperemia) to be moderately or severely intense (score ≥ 2) from the scoring scale from 0 to 3
  • Release of written informed consent by the patient

Exclusion Criteria

  • Patients suffering from a microbial infection requiring specific antimicrobial treatment
  • Patients who have taken the trial drugs during the week before enrolment
  • Patients who have taken corticosteroids or antibiotics during the week before enrolment
  • Ascertained or suspected hypersensitivity to trial drugs or to chemically correlated drugs or to other non-steroidal anti-inflammatory drugs or to mouthwashes in general
  • Patients who are unable to properly fill in the diary every day as provided for by the protocol
  • Ascertained or presumed pregnant or lactating women
  • Inclusion in any other clinical trial during the study

Arms & Interventions

Benzidamine hydrochloride

Active Comparator

Intervention: Benzidamine hydrochloride (Drug)

Ketoprofen lysine salt

Experimental

Intervention: Ketoprofen lysine salt (Drug)

Outcomes

Primary Outcomes

Duration of analgesic effects in hours

Time Frame: Up to 6 hours

Secondary Outcomes

  • Average severity of edema and hyperemia, assessed by investigator on a 4-point-scale(Up to day 8)
  • Average number of days required to obtain remission of pain(Up to day 8)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials